A new study shows women who call the hospitals in Oklahoma get confusing information about the state's abortion bans. One family lived through that confusion with dire consequences last month.
Missouri AG Andrew Bailey has issued a rule that severely limits adults and youth from receiving gender-affirming care. The rule, the first of its kind, is scheduled to take effect Thursday.
More women are serving in the U.S. military, and women are the fastest-growing group among U.S. veterans. The Veterans Administration is trying to meet their health needs, including pregnancy care.
In 2023, a record number of states have passed rules or legislation to eliminate youth gender-affirming care, but a record number of states have also moved to protect care for trans youth and adults.
Gender-affirming care for minors has been available in the U.S. for more than a decade and is endorsed by major medical associations, but it has come under attack in many conservative legislatures.
Billions of dollars are headed to state and local governments to address the opioid crisis. If the federal government fails to oversee how the money is spent, advocates worry it will be wasted.
The U.S. desperately needs more Black and Hispanic doctors, research shows. But financial pressures and discrimination can keep young people from even applying to med school.
Millions of Americans suffer from long COVID, which can have debilitating physical effects, including fatigue and difficulty breathing. Yet many patients feel abandoned, as federal aid winds down.
Anthony Comstock pushed Congress to crack down on what he saw as harmful vices, such as pornography and contraception. An 1873 law named for him has appeared in recent court battles over abortion.
A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.
The start of pregnancy — as well as exactly when that happens — is a hot topic in some state legislatures and U.S. courts. Understanding the nuances of what happens when has never been more important.
As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.